about
sameAs
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progressionThe 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cellsPandemic vaccine preparedness--have we left something behind?Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals.Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workers.A variant in the CD209 promoter is associated with severity of dengue disease.Lipid-based nanoparticles as nonviral gene delivery vectors.TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22.Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cells.HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines.Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharideA dimerizable cationic lipid with potential for gene delivery.Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells.Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b.Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells.Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication.Inhibition of influenza H5N1 invasion by modified heparin derivatives
P50
Q28304978-ECD7AD5E-6A8F-4767-BFEE-599A266CA7A5Q28594819-4C13AAC1-E674-4531-86CB-EDFE418FC55CQ30227832-95D947FC-7614-43A0-8B7C-ED6BBE83555EQ30397298-5DFF0860-41D6-4C0F-A904-187F0FF247F1Q30419757-D93776C0-1639-47B4-8649-67E037C303FFQ34412344-36D935B2-7200-4F15-B49F-8619B2F8088AQ34897554-41F7BE36-88E2-4A1C-A06D-7C6646A5494DQ35076765-CBD8EEBB-A53B-4503-B26F-92DA776B4542Q35618854-0C413079-B2AE-4DB7-80A0-DE5A8B14C5D9Q36760097-1F334E23-E5B0-4921-9E80-D9658E4B24A4Q36760097-49192767-05B8-4BD0-A021-03F95BBF63BAQ37639939-1626F422-98D5-4A3F-84BB-7FBC9A798941Q38390745-D363CD6E-7BD2-4267-9C03-DD165FEB6376Q38810619-08BAD812-3C9B-4C8D-A802-C25A66D9634AQ39414191-51D46A39-67DC-4455-86E0-9CAEAB66FFC7Q39968970-3CD42221-1D5B-4637-9C06-B759BE02EFF5Q40002798-8C52BB85-1696-4A62-AFB8-3BE7D02FDB50Q40139019-70A9BF2F-31B4-43D3-92D3-985205DA0470Q40279626-FCA4F845-C57F-48A7-9B16-1F7C8FFC85E1Q40367933-118BA87F-1E36-4AE8-B18B-FA155364620FQ41721059-8F828320-AE99-42A0-AEFB-0C35DD68AD09Q42252136-D03B6A2C-CBEA-4E00-BAB7-06307017682EQ43837736-454BF093-D4F7-4CFA-8C10-9B812FA4505DQ56833667-F17CE28B-C016-4F42-926F-CAC618A614E6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Kajaste-Rudnitski
@ast
Anna Kajaste-Rudnitski
@en
Anna Kajaste-Rudnitski
@es
Anna Kajaste-Rudnitski
@nl
type
label
Anna Kajaste-Rudnitski
@ast
Anna Kajaste-Rudnitski
@en
Anna Kajaste-Rudnitski
@es
Anna Kajaste-Rudnitski
@nl
prefLabel
Anna Kajaste-Rudnitski
@ast
Anna Kajaste-Rudnitski
@en
Anna Kajaste-Rudnitski
@es
Anna Kajaste-Rudnitski
@nl
P106
P1153
8344219300
P21
P31
P496
0000-0003-1549-2426